Published in Lab Invest on February 01, 2006
Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther (2006) 2.71
Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol (2008) 1.80
Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One (2012) 1.76
Human dermis harbors distinct mesenchymal stromal cell subsets. J Invest Dermatol (2011) 1.37
Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev (2008) 1.36
Epithelial-mesenchymal transition in cells expanded in vitro from lineage-traced adult human pancreatic beta cells. PLoS One (2009) 1.32
White adipose tissue development in zebrafish is regulated by both developmental time and fish size. Dev Dyn (2010) 1.19
Mesenchymal stem cell-based therapy. Mol Pharm (2012) 1.09
Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes. Mol Ther (2011) 1.09
Concise review: mesenchymal stem cells for diabetes. Stem Cells Transl Med (2011) 1.06
Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy. J Cell Mol Med (2008) 0.99
Concise review: pancreas regeneration: recent advances and perspectives. Stem Cells Transl Med (2012) 0.98
Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus. J Diabetes Res (2015) 0.95
Engineering mesenchymal stem cells for regenerative medicine and drug delivery. Methods (2015) 0.93
Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation. Ups J Med Sci (2010) 0.93
Evidence for epithelial-mesenchymal transition in adult human pancreatic exocrine cells. J Histochem Cytochem (2010) 0.92
Pancreatic stem cells remain unresolved. Stem Cells Dev (2014) 0.89
CD13 promotes mesenchymal stem cell-mediated regeneration of ischemic muscle. Front Physiol (2014) 0.88
Fabrication and characterization of multiscale electrospun scaffolds for cartilage regeneration. Biomed Mater (2013) 0.87
CD13 regulates anchorage and differentiation of the skeletal muscle satellite stem cell population in ischemic injury. Stem Cells (2014) 0.87
β-Cell Generation: Can Rodent Studies Be Translated to Humans? J Transplant (2011) 0.85
Ex-vivo Expansion of Adult Human Pancreatic Beta-Cells. Rev Diabet Stud (2008) 0.84
Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes. Adv Biomed Res (2014) 0.83
Making β cells from adult cells within the pancreas. Curr Diab Rep (2013) 0.81
Present and future cell therapies for pancreatic beta cell replenishment. World J Gastroenterol (2012) 0.81
Immunomodulative effects of mesenchymal stem cells derived from human embryonic stem cells in vivo and in vitro. J Zhejiang Univ Sci B (2011) 0.80
Generation of Islet-like Cell Aggregates from Human Adipose Tissue-derived Stem Cells by Lentiviral Overexpression of PDX-1. Int J Organ Transplant Med (2015) 0.79
Purified human pancreatic duct cell culture conditions defined by serum-free high-content growth factor screening. PLoS One (2012) 0.78
Establishment of a pancreatic β cell proliferation model in vitro and a platform for diabetes drug screening. Cytotechnology (2013) 0.78
Ontogenetic development of adipose tissue in grass carp (Ctenopharyngodon idellus). Fish Physiol Biochem (2015) 0.77
Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas. Respir Res (2014) 0.76
Cell therapies for pancreatic beta-cell replenishment. Ital J Pediatr (2016) 0.76
High-risk corneal allografts: A therapeutic challenge. World J Transplant (2016) 0.75
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells. Stem Cells Int (2016) 0.75
Mesenchymal Stem Cells Derived from Human Exocrine Pancreas Spontaneously Express Pancreas Progenitor-Cell Markers in a Cell-Passage-Dependent Manner. Stem Cells Int (2016) 0.75
Multipotent pancreas progenitors: Inconclusive but pivotal topic. World J Stem Cells (2015) 0.75
Dynamic expression and localization of c-MET isoforms in the developing rat pancreas. Int J Clin Exp Pathol (2014) 0.75
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86
Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med (2006) 2.41
Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes (2002) 2.36
Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med (2006) 2.21
A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol (2005) 2.12
Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes (2004) 1.98
Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation (2006) 1.89
Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One (2012) 1.76
Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes (2002) 1.61
Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass. J Clin Endocrinol Metab (2005) 1.61
Granzyme B: a natural born killer. Immunol Rev (2003) 1.61
Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Cell Metab (2010) 1.49
Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes (2004) 1.46
The blood-testis and blood-epididymis barriers are more than just their tight junctions. Biol Reprod (2011) 1.44
A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes (2002) 1.43
Beta-score: an assessment of beta-cell function after islet transplantation. Diabetes Care (2005) 1.35
Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology (2003) 1.34
Strategic opportunities in clinical islet transplantation. Transplantation (2005) 1.34
Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes (2002) 1.32
Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am J Transplant (2003) 1.26
Portal venous pressure changes after sequential clinical islet transplantation. Transplantation (2002) 1.24
Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab (2004) 1.23
Immunoprotective sertoli cells: making allogeneic and xenogeneic transplantation feasible. Reproduction (2009) 1.18
Combination therapy with glucagon-like peptide-1 and gastrin induces beta-cell neogenesis from pancreatic duct cells in human islets transplanted in immunodeficient diabetic mice. Cell Transplant (2008) 1.16
Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme. Am J Transplant (2007) 1.14
The portal immunosuppressive storm: relevance to islet transplantation? Ther Drug Monit (2005) 1.14
Blood-tissue barriers: morphofunctional and immunological aspects of the blood-testis and blood-epididymal barriers. Adv Exp Med Biol (2012) 1.13
Estimation of pancreas weight from donor variables. Cell Transplant (2006) 1.13
Synaptosome-associated protein of 25 kilodaltons modulates Kv2.1 voltage-dependent K(+) channels in neuroendocrine islet beta-cells through an interaction with the channel N terminus. Mol Endocrinol (2002) 1.13
Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon. Transplantation (2006) 1.12
XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes (2005) 1.12
Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Ther (2006) 1.08
The standardization of pancreatic donors for islet isolations. Transplantation (2005) 1.07
Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng (2005) 1.06
Differential effects of phthalates on the testis and the liver. Biol Reprod (2004) 1.06
Factors influencing the collagenase digestion phase of human islet isolation. Transplantation (2007) 1.03
Comparison of aortic valve allograft decellularization techniques in the rat. J Biomed Mater Res A (2006) 1.01
Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes (2002) 1.00
Identification of a novel human granzyme B inhibitor secreted by cultured sertoli cells. J Immunol (2006) 1.00
Long-term survival of neonatal porcine Sertoli cells in non-immunosuppressed rats. Xenotransplantation (2003) 0.98
Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells. Cell Transplant (2008) 0.98
Harnessing the immunomodulatory properties of Sertoli cells to enable xenotransplantation in type I diabetes. Immunol Invest (2003) 0.97
Decellularization reduces the immune response to aortic valve allografts in the rat. J Thorac Cardiovasc Surg (2005) 0.95
Pancreas divisum: a study of the cadaveric donor pancreas for islet isolation. Pancreas (2005) 0.94
Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation (2002) 0.93
Neonatal porcine islets exhibit natural resistance to hypoxia-induced apoptosis. Transplantation (2006) 0.93
Suppression of islet allogeneic immune response by indoleamine 2,3 dioxygenase-expressing fibroblasts. J Cell Physiol (2007) 0.93
Changes in liver enzymes after clinical islet transplantation. Transplantation (2003) 0.92
Immune mechanisms associated with the rejection of encapsulated neonatal porcine islet xenografts. Xenotransplantation (2006) 0.92
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-- executive summary. Xenotransplantation (2009) 0.92
Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice. Cardiovasc Res (2013) 0.91
Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice. Cell Transplant (2008) 0.90
Detection of microbial contamination during human islet isolation. Cell Transplant (2007) 0.90
Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation. Eur J Cardiothorac Surg (2005) 0.90
Enriched human pancreatic ductal cultures obtained from selective death of acinar cells express pancreatic and duodenal homeobox gene-1 age-dependently. Rev Diabet Stud (2004) 0.90
Clinical islet transplant: current and future directions towards tolerance. Immunol Rev (2003) 0.90
Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method. Transplantation (2004) 0.90
Pulsatile intravenous insulin therapy: the best practice to reverse diabetes complications? Med Hypotheses (2009) 0.89
Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes. Int J Biochem Cell Biol (2004) 0.88
Long-term survival of intratesticular porcine islets in nonimmunosuppressed beagles. Transplantation (2003) 0.88
Immunoprotective properties of primary Sertoli cells in mice: potential functional pathways that confer immune privilege. Biol Reprod (2012) 0.88
Pancreatic islet autotransplantation with completion pancreatectomy in the management of uncontrolled pancreatic fistula after whipple resection for ampullary adenocarcinoma. Pancreas (2006) 0.87
Human islet transplantation from pancreases with prolonged cold ischemia using additional preservation by the two-layer (UW solution/perfluorochemical) cold-storage method. Transplantation (2002) 0.87
Reversal of diabetes in pancreatectomized pigs after transplantation of neonatal porcine islets. Diabetes (2005) 0.86
Maintenance of mouse, rat, and pig pancreatic islet functions by coculture with human islet-derived fibroblasts. Cell Transplant (2006) 0.86
Clinical islet transplantation at the University of Alberta--the Edmonton experience. Clin Transpl (2005) 0.86
Quantitative assessment of collagenase blends for human islet isolation. Transplantation (2005) 0.86
Short-term administrations of a combination of anti-LFA-1 and anti-CD154 monoclonal antibodies induce tolerance to neonatal porcine islet xenografts in mice. Diabetes (2010) 0.86
Alginate modification improves long-term survival and function of transplanted encapsulated islets. Tissue Eng Part A (2009) 0.85